Abstract. Non-canonical WNT and planar cell polarity (PCP) are overlapping but distinct signaling pathways, which control convergent extension, neural tube closure, orientation of cilia and sensory hair cells, axon guidance, and cell motility. Non-canonical WNT signals, regulated by the interaction of WNT, WNT antagonist, Frizzled and ROR2, are transduced to JNK, ROCK, PKC, MAP3K7, and NFAT signaling cascades. PCP signals, regulated by the interaction of VANGL-PRICKLE complex, CELSR and Frizzled-DVL complex, are transduced to JNK, ROCK, and other uncharacterized signaling cascades. PTK7 signaling, regulated by SEMA6 and Plexin-A family members, affects PCP pathway through VANGL. Here, integrative genomic analyses on WNT5A, WNT5B, WNT11, FZD3, FZD6, ROR1, ROR2, RYK, CELSR1, CELSR2, CELSR3, VANGL1, VANGL2, PRICKLE1, PRICKLE2, PTK7, SEMA6A, SEMA6B, SEMA6C and SEMA6D were carried out. PTK7 and SEMA6A were expressed in undifferentiated embryonic stem (ES) cells, SEMA6A in endodermal progenitors, CELSR1, VANGL1 and PTK7 in gastrointestinal tumors. CELSR2, PRICKLE2 and SEMA6C were expressed in fetal brain, CELSR2, PRICKLE1 and SEMA6A in adult brain, WNT5A and CELSR3 in adult brain tumors. These facts indicate class switches of non-canonical WNT or PCP signaling molecules during embryogenesis and carcinogenesis. TCF/LEF-, SP1-, and 5 bHLH-binding sites within human PTK7 promoter were conserved in chimpanzee, rhesus monkey, mouse, and rat PTK7 orthologs, which explained the mechanism of PTK7 upregulation in colorectal cancer. NANOG-, SOX2-, and POU5F1 (OCT3/OCT4)-binding sites within intron 1 of the human SEMA6A gene were conserved in chimpanzee, rhesus monkey, mouse, and rat SEMA6A orthologs, which explained the mechanism of SEMA6A upregulation in undifferentiated ES cells. Most of noncanonical WNT or PCP signaling molecules, except PTK7 and SEMA6A, were not frequently expressed in undifferentiated human ES cells. Non-canonical WNT or PCP signaling pathway, activated to orchestrate gastrulation and neurulation, was relatively downregulated in undifferentiated ES cells derived from inner cell mass of blastocysts.
Here, expression analyses on WNT5A, WNT5B, WNT11, FZD3, FZD6, ROR1, ROR2, RYK, CELSR1, CELSR2, CELSR3, VANGL1, VANGL2, PRICKLE1, PRICKLE2, PTK7, SEMA6A, SEMA6B, SEMA6C, and SEMA6D were carried out. Most of these genes were preferentially expressed in fetal tissues, adult tissues, and tumors, while PTK7 and SEMA6A in undifferentiated human embryonic stem (ES) cells. Comparative genomic analyses on PTK7 and SEMA6A genes were further carried out to elucidate the mechanisms of PTK7 and SEMA6A expression.
Materials and methods
In silico expression analyses. Expressed sequence tags (ESTs) derived from human genes encoding non-canonical WNT or PCP signaling molecules were searched for using the BLAST programs as described previously (42) (43) (44) Exon-intron structure of the human PTK7 and SEMA6A genes. Human genome sequences corresponding to PTK7 and SEMA6A genes were searched for with the BLAST programs as described previously (46) (47) (48) . Exon-intron boundaries were determined based on the consensus sequence of exon-intron junctions ('gt ..... ag' rule of intronic sequence) and codon usage within the coding region.
Comparative genomics on the PTK7 and SEMA6A genes. Human genome sequences around the PTK7 and SEMA6A genes were compared with chimpanzee, rhesus monkey, mouse and rat genome sequences using the BLAST programs. Transcription factor-binding sites within the evolutionarily conserved regions were then searched for using the Match program, Genetyx program, and the manual curation as described previously (49) (50) (51) . Comparative genomic analyses revealed that the 5'-promoter region of the human PTK7 gene, corresponding to nucleotide position -991 to -559, were well conserved in chimpanzee, rhesus monkey, mouse, and rat PTK7 orthologs ( Fig. 2A) .
Results

Expression profile of non-canonical
Transcription factor-binding sites within the conserved region of PTK7 5'-flanking promoter region were next searched for. Five bHLH-binding sites, SP1-binding site, and TCF/ LEF-binding site within human, chimpanzee, rhesus monkey, mouse, and rat PTK7 promoters were completely conserved (Fig. 2B) .
Comparative genomic analyses on SEMA6A orthologs. BLAST programs revealed that the human SEMA6A gene was located within AC027304.4 and AC008524.6 genome sequences, chimpanzee SEMA6A gene within NW_001235419.1 genome sequence, rhesus monkey SEMA6A gene within AC169874.1 genome sequence, mouse Sema6a gene within AC121783.2 genome sequence, and rat Sema6a gene within AC094771.5 genome sequence.
Exon-intron structure of the human SEMA6A gene was determined based on the consensus sequence of exon-intron junctions. The human SEMA6A gene, consisting of 19 exons, was about 130 kb in size (Fig. 3) . The first and last exons were larger than the other exons. Intron 1 was about 70 kb in size. Comparative genomic analyses revealed that the 5'-promoter region and intron 1 of human SEMA6A gene was relatively well conserved in mouse Sema6a gene.
Transcription factor-binding sites within the conserved promoter regions and intron 1 of SEMA6A orthologs were next searched for. NANOG-, SOX2-, and POU5F1 (OCT3/ OCT4)-binding sites within intron 1 of human SEMA6A gene were completely conserved in chimpanzee, rhesus monkey, mouse, and rat SEMA6A orthologs (Fig. 3) .
Discussion
Integrative genomic analyses on non-canonical WNT or PCP signaling molecules were carried out in this study. PTK7 and SEMA6A were expressed in undifferentiated ES cells, SEMA6A in endodermal progenitors, CELSR1, VANGL1 and PTK7 in gastrointestinal tumors (Fig. 1B) . CELSR2, PRICKLE2 and SEMA6C were expressed in fetal brain, CELSR2, PRICKLE1 and SEMA6A in adult brain, WNT5A and CELSR3 in adult brain tumors (Fig. 1B) . These facts indicate class switches of non-canonical WNT or PCP signaling molecules during embryogenesis and carcinogenesis.
Comparative genomic analyses on the PTK7 and SEMA6A genes were further carried out to elucidate the mechanisms of their expression in undifferentiated ES cells. Five bHLHbinding sites, SP1-binding site, and TCF/LEF-binding site within the human PTK7 5'-promoter region were conserved in chimpanzee, rhesus monkey, mouse, and rat PTK7 genes (Fig. 2) . NANOG-, SOX2-, and POU5F1-binding sites within intron 1 of human SEMA6A gene were conserved in chimpanzee, rhesus monkey, mouse, and rat SEMA6A genes (Fig. 3) .
PTK7 is a transmembrane protein with extracellular immunoglobulin-like domains and a cytoplasmic tyrosine kinase-like domain (39) . PTK7 is homologous to ROR1, ROR2 and RYK receptor tyrosine kinases; however, PTK7 is a pseudokinase without detectable catalytic tyrosine kinase activity due to amino-acid substitution within the catalytic domain (54) . PTK7, also known as CCK4, is upregulated in colorectal cancer. Because the canonical WNT signaling pathway is frequently activated in colorectal cancer, conserved TCF/LEF-binding site within the PTK7 promoter region explains the mechanism of PTK7 upregulation in colorectal cancer.
SEMA6 family members are transmembrane-type ligands for Plexin-A family receptors to regulate axon guidance and cell motility (18, 19) . SEMA6A is reported to bind to Plexin-A2, Plexin-A4, while SEMA6C and SEMA6D to Plexin-A1. We also investigated the expression profile of Plexin-A family members to identify that Plexin-A1 was expressed in undifferentiated human ES cells (Katoh and Katoh, unpublished data). SEMA6D signal is transduced through the Plexin-A1 and PTK7 receptor complex for the activation of Rac signaling cascade rather than Rho signaling cascade (18) . SEMA6A signal transduction through Plexin-A1 and PTK7 receptor complex in undifferentiated human ES cells should be investigated in the future.
Most of non-canonical WNT or PCP signaling molecules, except PTK7 and SEMA6A, were not frequently expressed in undifferentiated human ES cells. Non-canonical WNT or PCP signaling pathway, activated to orchestrate gastrulation and neurulation, was relatively downregulated in undifferentiated ES cells derived from the inner cell mass of blastocysts.
